Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)

Market Cap	2.13B
Revenue (ttm)	586.52M
Net Income (ttm)	-228.38M
Shares Out	563.78M
EPS (ttm)	-0.42
PE Ratio	n/a
Forward PE	117.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	397,000
Average Volume	46,660
Open	3.650
Previous Close	3.660
Day's Range	3.650 - 3.780
52-Week Range	3.020 - 11.680
Beta	n/a
RSI	59.97
Earnings Date	Jun 20, 2025

About HKG:2576

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial project management system; eArchives, an electric trail master file; eCollect, an electronic data capture system; eCollege, a training management s...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 627
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2576

Financial Performance

In 2024, HKG:2576's revenue was 551.16 million, a decrease of -3.84% compared to the previous year's 573.14 million. Losses were -214.61 million, -38.11% less than in 2023.

Financial numbers in CNY